tiprankstipranks
Trending News
More News >
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (DE:2TZ)
FRANKFURT:2TZ
Germany Market

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (2TZ) Income Statement

Compare
0 Followers

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Income Statement

Last quarter (Q3 2024), Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S's total revenue was ¥1.65B, a decrease of -3.43% from the same quarter last year. In Q3, Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S's net income was ¥146.14M. See Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 8.22B¥ 8.25B¥ 6.91B¥ 6.60B¥ 6.99B
Gross Profit
¥ 3.62B¥ 3.29B¥ 2.76B¥ 2.58B¥ 2.95B
Operating Expenses
¥ 2.52B¥ 2.57B¥ 2.14B¥ 1.98B¥ 2.38B
Depreciation and Amortization
¥ 130.13M¥ 116.56M¥ 115.53M¥ 110.85M¥ 98.15M
EBITDA
¥ 1.26B¥ 1.11B¥ 991.28M¥ 878.91M¥ 846.19M
Operating Income
¥ 1.10B¥ 980.05M¥ 866.68M¥ 785.18M¥ 759.02M
Other Income/Expenses
¥ -1.61M¥ 138.80K¥ 6.13M¥ -17.12M¥ -15.88M
Pretax Income
¥ 1.10B¥ 980.19M¥ 872.81M¥ 768.06M¥ 743.15M
Net Income
¥ 986.71M¥ 861.79M¥ 769.14M¥ 661.70M¥ 625.57M
Per Share Metrics
Basic EPS
¥ 1.28¥ 1.12¥ 1.00¥ 0.86¥ 0.81
Diluted EPS
¥ 1.28¥ 1.11¥ 1.00¥ 0.86¥ 0.81
Weighted Average Shares Outstanding
770.87M 769.46M 768.87M 768.87M 768.87M
Weighted Average Shares Outstanding (Diluted)
770.87M 776.39M 769.14M 769.42M 772.31M
Currency in CNY

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Earnings and Revenue History